• OPEN AN ACCOUNT
Indian Indices
Sensex
85,041.45 -367.25
( -0.43%)
Global Indices
Nasdaq
48,728.27 -23.90
(-0.05%)
Dow Jones
6,949.98 -3.07
(-0.04%)
Hang Seng
50,641.54 233.75
(0.46%)
Nikkei 225
9,870.68 -18.54
(-0.19%)
Forex
USD-INR
89.83 0.26
(0.29%)
EUR-INR
105.77 0.25
(0.24%)
GBP-INR
121.29 0.43
(0.36%)
JPY-INR
0.58 0.00
(0.43%)

EQUITY - MARKET SCREENER

Saakshi Medtech & Panels Ltd
Industry :  Diversified - Medium / Small
BSE Code
ISIN Demat
Book Value()
91668
INE0PSK01027
55.5305279
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SAAKSHI
70.39
331.84
EPS(TTM)
Face Value()
Div & Yield %
2.67
10
0
 

KEC International slides after PGCIL bars firm from new tenders
Nov 19,2025
The restriction, effective November 18, does not affect ongoing PGCIL projects.

In its filing, KEC said the action stems from alleged contractual violations tied to an issue first disclosed in March 2025. The company said it is reviewing its options, including legal steps and seeking a reconsideration from PGCIL.

KEC added that the development will not materially affect its operations or financials, supported by a strong order book and tender pipeline. It reiterated its adherence to high standards of governance and compliance.

The company is a global EPC player with operations across power transmission and distribution, civil infrastructure, transportation, renewables, oil and gas pipelines, and cables.

KEC’s consolidated net profit jumped 88.21% to Rs 160.75 crore in Q2 FY26, while revenue from operations rose 19.13% to Rs 6,091.56 crore. Its year to date order intake has crossed Rs 17,000 crore, up about 17% from last year.